CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 94 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $6,000 | +20.0% | 1,394 | 0.0% | 0.00% | – |
Q1 2022 | $5,000 | 0.0% | 1,394 | -6.6% | 0.00% | – |
Q4 2021 | $5,000 | 0.0% | 1,493 | -1.3% | 0.00% | – |
Q3 2021 | $5,000 | -16.7% | 1,512 | +1.4% | 0.00% | – |
Q2 2021 | $6,000 | -25.0% | 1,491 | -1.4% | 0.00% | – |
Q1 2021 | $8,000 | -38.5% | 1,512 | +51.2% | 0.00% | – |
Q4 2020 | $13,000 | +30.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $10,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2020 | $10,000 | +233.3% | 1,000 | +400.0% | 0.00% | – |
Q4 2018 | $3,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |